The odds are against Merck & Co. prevailing in a wrongful-death civil Vioxx lawsuit being tried in Texas, an analyst at Prudential Equity Group says. 賠率是對默克公司普遍存在的不法行為死亡公務員Vioxx的訴訟，正在嘗試在德克薩斯州的一位分析師保德信證券集團的說。 It is the first Vioxx-related lawsuit to come to trial.它是第一個萬絡有關的官司來審判。

The plaintiff in the case has alleged that Merck’s Vioxx contributed to the sudden death of a man in Texas who had been using the drug for about eight months.原告在案件據稱，默克公司的Vioxx的貢獻的猝死，一名男子在得克薩斯州誰一直在使用的藥物為約八個月。

“We think the odds are against Merck , and that that share price could contract more than 5%, but less than 10%, if a sizable award is meted out against the company,” wrote Anderson, who has a neutral rating on the stock. “我們認為， 賠率是對默克公司 ，並認為股價可以合同5 ％以上，但低於10 ％ ，如果一個可觀的獎勵是平時對公司，寫道： ”安德森，誰有一個中立的股票評級。

Anderson also said that a victory for Merck is likely to raise the stock price by the same percentage range.安德森還表示，勝利，為默克公司很可能提高股票價格是由相同的百分比範圍。

Source:資料來源： MarketWatch 【 MarketWatch

The first vioxx lawsuit is coming to an end soon.第一Vioxx的訴訟即將結束不久。 Lawyers on both sides said they expected to make their final arguments Wednesday, after plaintiff’s lawyer Mark Lanier presents two rebuttal witnesses Tuesday.律師對雙方都表示，他們預期，使他們最後的論點週三後，原告的律師馬克拉尼爾兩個辯駁證人週二。 Both legal teams worked Monday to hash out issues jurors will consider in reaching a verdict.雙方的法律團隊工作，週一到哈希出來的問題，陪審員會考慮在達成一項判決。